News

Displaying 21 - 40 of 56

Contingency management

Contingency management can help retain people in treatment and strengthen abstinence

Ahead of World Mental Health Day on 10 October, the EMCDDA has published a new review on how contingency management can help treat those with substance use disorders.

Third EMDAS graduation ceremony at the EMCDDA

The third group of students graduating from the European Masters in Drug and Alcohol Studies (EMDAS), will receive their diplomas at a ceremony at the EMCDDA on 23 September. EMDAS is a...

ESPAD upcoming report

Upcoming ESPAD report on substance use among school students

The latest European data on substance use among 15–16-year-old school students will be released next week (20 September). The findings are based on a 2015 survey in 35 European countries

European Parliament building

EMCDDA Director presents the European Drug Report 2016 to members of the Civil Liberties, Justice and Home Affairs (LIBE) Committee of the European Parliament

The Director will present the European Drug Report 2016 on 8 September 2016 to the members of the Civil Liberties, Justice and Home Affairs (LIBE) Committee of the European Parliament. The presentation...

NPS

New psychoactive substances: Commission proposes new ban and strengthens the EU's Early Warning System and risk assessment

Today, the European Commission has proposed to subject the new psychoactive substance MDMB-CHMICA (sometimes referred to as ‘Black Mamba’) to control measures across the European Union.

Picture ambulance

New EMCDDA report sheds light on drug-related hospital emergencies

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related poisoning and other harms, requiring some kind of medical assistance.

Close-up of virus

New EMCDDA report shows grounds for hope in treating hepatitis C

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks...

Libe Committée visit 2016

European Parliament LIBE Committee members pay fact-finding visit to the EMCDDA

Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) start a two-day visit to the EMCDDA today where they will hear presentations on the agency’s contribution to...

EMCDDA Director at German Bundestag hearing on new psychoactive substances

EMCDDA Director Alexis Goosdeel is in Berlin today where he is speaking at a public hearing at the German Parliament (Bundestag) on the issue of new psychoactive substances (NPS). The hearing is...

ENP group photo

EMCDDA conference takes stock of project with ENP partner countries

The EU drugs agency (EMCDDA) is hosting a conference in Lisbon today marking the end of a 30-month technical cooperation project within the framework of the European Neighbourhood Policy (ENP).

esdss poster

Fifth European drugs summer school opens today in Lisbon

The fifth European drugs summer school — ‘Illicit drugs in Europe: demand, supply and public policies’ — opened today in Lisbon and will run until 8 July. The initiative, organised by ISCTE...

EMCDDA publishes its first report on health responses to new psychoactive substances

In its latest report, released today ahead of International day against drug abuse and illicit trafficking (26 June), the EMCDDA presents its first analysis of the health responses to NPS.

Speech by Alexis Goosdeel at National Drugs Coordinators’ meeting, Dutch Presidency

EMCDDA Director, Alexis Goosdeel, attended the EU National Drugs Coordinators' meeting on 'Drugs and Nightlife' in Amsterdam, where he presented his views on developing efficient interventions for recreational drug use.

European Drug Report 2016 promotional banner

Coming up: European Drug Report 2016

What drugs are causing the most harm and concern today? What are the most recent developments in drug prevention, treatment and policy? These and other questions will be explored on 31 May...

United Nations General Assembly Hall

EMCDDA to join EU delegation at UNGASS 2016 in New York

The 2016 UN General Assembly Special Session (UNGASS) on drugs will convene at the UN headquarters in New York from 19–21 April. This meeting represents a major opportunity for the international community...

United Nations General Assembly Hall

Follow the EMCDDA delegation at UNGASS 2016

The UN General Assembly Special Session (UNGASS) on drugs, taking place from 19–21 April 2016 in New York, is a major political moment and an opportunity for the international community to review...

Director's speech: presentation of the EU Drug Markets Report, LIBE Committee, European Parliament, Brussels

Dear Chair, Ladies and Gentlemen, It is a great pleasure to present to you today the second EU Drug Markets Report that was launched on Tuesday with Commissioner Avramopoulos and my colleague...

Alexis Goosdeel, EMCDDA Director

Speech by EMCDDA Director on the occasion of the launch of EU Drug Markets Report, Brussels

Ladies and Gentlemen, It is a great pleasure to be here today with Commissioner Avramopoulos and with my colleague Rob Wainwright, Director of Europol, to launch the second EU Drug Markets Report...

59th Commission on Narcotic Drugs, 14–22 March 2016, Vienna

The United Nations Commission on Narcotic Drugs (CND), the central UN policy-making body in drug-related matters, opens its 59th session in Vienna this month (14–22 March).

Evaluation of the EU Drugs Strategy and Action Plan (2013–2016): public consultation

The EU Drugs Strategy provides a political framework and priorities for action in the field of drug policies for the period 2013–2020. It is structured around two policy fields: drug demand reduction...